The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts. 

Related News Articles

Headline
Health care and other organizations that operate Unitronics Programmable Logic Controllers should protect the devices from potential compromise through default…
Headline
A Russian national Dec. 4 pleaded guilty to his role in developing and deploying a suite of malware tools known as Trickbot, used to launch ransomware attacks…
Headline
The Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center is urging hospitals and other critical infrastructure to take…
Headline
Cyber actors attacking the Okta Help Center customer support management system in October downloaded a report containing the names and email addresses of all…
Headline
The U.S. Cybersecurity and Infrastructure Security Agency, U.K. National Cyber Security Centre and other global partners this week released recommended…
Headline
The Cybersecurity and Infrastructure Security Agency, Federal Bureau of Investigation, Multi-State Information Sharing and Analysis Center and international…